1. ClearMinds vs. Reveri Health
Company Profile: Reveri Health
Positioning: "Clinical hypnosis backed by Stanford Medicine"
Strengths:
* Founded by Dr. David Spiegel (Stanford psychiatrist, 50+ years hypnosis research)
* Strong academic and medical credentials
* Evidence-based approach with published research
* Medical professional endorsements
* Focus on pain, anxiety, insomnia, smoking cessation
Business Model:
* B2C app ($14.99/month or $99.99/year)
* Some B2B partnerships emerging
* Individual session focus (not community-based)
Market Position:
* Premium pricing justified by medical credentials
* Strong in clinical conditions (pain, insomnia)
* U.S.-focused market
________________


Direct Comparison:


Dimension
	Reveri Health
	ClearMinds
	Winner
	Clinical Credibility
	✅ Stanford Medicine affiliation
	✅ 65 years hypnotherapy research + SmartStartMinds (CQC)
	TIE
	Evidence Base
	Published research (Spiegel studies)
	Meta-analyses (d=1.17-1.58 PTSD, etc.)
	TIE
	Community Model
	❌ None - individual use only
	✅ 91,000+ members, 24/7 moderation
	ClearMinds
	Customer Support
	Standard support
	✅ 24/7 manned support + class-leading response times
	ClearMinds
	B2B Readiness
	🔶 Emerging, no enterprise infrastructure
	✅ Purpose-built workplace content, employer portal
	ClearMinds
	Personalization
	🔶 Session selection by user
	✅ Neuroindicator triage + intelligent routing
	ClearMinds
	Geographic Focus
	U.S. market
	UK market + UK legal compliance (Equality Act)
	ClearMinds (UK)
	Technology
	Standard app delivery
	AI coaching + assessment + community platform
	ClearMinds
	Pricing
	$99.99/year B2C
	£80-120/employee/year B2B
	Different segments
	Market Proven
	Newer to market
	100,000+ users, 4.5 years data
	ClearMinds
	Time to Market
	Available now
	Available now
	TIE
	



Strategic Assessment:
Reveri's Advantage: Stanford brand, U.S. market penetration, medical establishment credibility
ClearMinds' Advantage: Community infrastructure (cannot be replicated quickly), B2B-ready, UK market positioning, behavioral data from 100K+ users, intelligent triage system
Market Positioning: Not directly competitive - Reveri focuses on premium individual consumers in U.S., ClearMinds focuses on UK enterprise market with community-integrated model.
Threat Level: LOW - Different geographic markets, different business models, no community offering
________________
  ________________
2. ClearMinds vs. Nerva
Company Profile: Nerva
Positioning: "Digital gut-directed hypnotherapy for IBS"
Strengths:
* Niche focus on IBS (strong clinical evidence for hypnotherapy + IBS)
* AR/VR technology integration
* NICE recognition for gut-directed hypnotherapy
* 6-week program structure
* Some partnerships with healthcare providers
Business Model:
* B2C app (subscription model)
* Healthcare provider partnerships
* Condition-specific (IBS primarily)
Market Position:
* Technology innovation leader (AR/VR)
* Clinical validation for specific condition
* Growing in digital therapeutics space
________________


Direct Comparison
Dimension
	Nerva
	ClearMinds
	Winner
	Technology Innovation
	✅ AR/VR immersive experiences
	🔶 Standard app + AI
	Nerva
	Clinical Evidence (IBS)
	✅ NICE-recognized gut-directed hypnotherapy
	✅ NICE-recognized (same evidence base)
	TIE
	Condition Breadth
	❌ IBS-focused only
	✅ Anxiety, PTSD, pain, IBS, sleep, smoking
	ClearMinds
	Community
	❌ None
	✅ 91,000+ members
	ClearMinds
	Customer Support
	Standard support
	✅ 24/7 manned support + class-leading response times
	ClearMinds
	B2B Infrastructure
	❌ B2C focused
	✅ Employer portal, workplace content
	ClearMinds
	Market Scale
	Niche (IBS sufferers)
	Broad (multiple high-prevalence conditions)
	ClearMinds
	Personalization
	🔶 6-week program
	✅ Neuroindicator assessment + routing
	ClearMinds
	Geographic
	Global (limited UK-specific)
	UK-focused + legal compliance
	ClearMinds (UK)
	Price Point
	B2C subscription
	B2B enterprise pricing
	Different segments
	Strategic Assessment:
Nerva's Advantage: AR/VR technology leadership, strong single-condition focus, established in digital therapeutics space
ClearMinds' Advantage: Multi-condition platform, community infrastructure, B2B-ready, broader addressable market, UK positioning
Market Positioning: Nerva is technology innovator in narrow niche. ClearMinds is platform play across multiple conditions. Nerva's technology could be replicated by ClearMinds if needed, but ClearMinds' community cannot be quickly replicated by Nerva.
Threat Level: LOW-MEDIUM - Different market strategy (niche vs. platform), but could expand beyond IBS over time


  ________________
3. ClearMinds vs. HelloMind
Company Profile: HelloMind
Positioning: "Personalized hypnotherapy programs"
Strengths:
* User customization and tailored programs
* Multiple condition coverage (anxiety, stress, sleep, habits)
* Consumer-friendly interface
* Established B2C brand in Europe
* Multiple language support
Business Model:
* B2C subscription app
* Individual programs purchased
* Consumer self-service model
Market Position:
* European market presence
* Consumer wellness positioning
* Mid-market pricing
________________
Direct Comparison
Dimension
	HelloMind
	ClearMinds
	Winner
	Personalization
	🔶 User selects programs
	✅ Neuroindicator diagnostic assessment
	ClearMinds
	Condition Coverage
	✅ Anxiety, stress, sleep, habits
	✅ Plus PTSD, pain, IBS (broader clinical)
	ClearMinds
	Clinical Evidence
	🔶 Limited published evidence
	✅ 65 years meta-analyses, effect sizes
	ClearMinds
	Community
	❌ None
	✅ 91,000+ members, 24/7 moderation
	ClearMinds
	Customer Support
	Standard support
	✅ 24/7 manned support + class-leading response times
	ClearMinds
	B2B Infrastructure
	❌ B2C only
	✅ Enterprise-ready
	ClearMinds
	Technology
	Standard app
	AI coaching + assessment + community
	ClearMinds
	Market Data
	Limited disclosure
	100,000+ users, 4.5 years behavioral data
	ClearMinds
	Geographic
	European focus
	UK-focused + compliance
	ClearMinds (UK)
	Price
	B2C mid-market
	B2B premium
	Different segments
	Strategic Assessment:
HelloMind's Advantage: Established European consumer brand, multi-language support, user-friendly consumer experience
ClearMinds' Advantage: Diagnostic assessment (not just browsing), community infrastructure, clinical depth, B2B infrastructure, behavioral data at scale, UK market positioning
Market Positioning: HelloMind is consumer wellness app. ClearMinds is clinical resolution platform. HelloMind competes in "browse and choose" consumer market. ClearMinds competes in "assess and resolve" enterprise market.
Threat Level: LOW - Different business model (B2C vs. B2B), no enterprise infrastructure, no community, limited clinical depth
________________